The Clinical Research Center is currently participating in the Expedition 3 Study, a trial for those who have mild Alzheimer’s disease. The investigational drug solanezumab is being evaluated in this worldwide trial to see whether it helps slow the worsening of Alzheimer’s in patients who currently have mild disease.
When we announced our research center would be involved in the solunezemab study and began advertising it on television, we were not surprised to receive lots of phone calls from community members who wanted to participate in an Alzheimer’s prevention study. However, Expedition 3 is not a prevention study, so we had to explain that to a lot of disappointed callers.
Interestingly, there is now a large prevention–focused study investigating the Alzheimer’s disease prevention possibilities of solanezumab, the same drug under investigation in Expedition 3. The Alzheimer’s prevention study is called the A4 Study and participants between 65-86 years old with normal thinking and memory who may be at risk of developing Alzheimer’s disease are being sought. The Research Center is not part of the A4 study. However, we would like to help get the word out about this exciting research. The A4 study began recruiting subjects in June, 2014. You can read more about the A4 study, including the location of clinical trial sites, at www.a4study.org.
We are pleased to know about the A4 study because the Research Center is about to launch a new advertising campaign for the Expedition 3 solanezumab study. Our new campaign will include information about our study for those with mild Alzheimer’s disease in the preshow programs at two Corvallis movie theaters, the Carmike on Circle Boulevard and Regal Cinemas on Ninth Street. At least this time we can direct those callers interested in Alzheimer’s disease prevention to the A4 study!
If you are interested in learning more about the Expedition 3 Study, contact the Clinical Research Center at 541-766-2163 or send an email to research@corvallisclinic.com.
– Julie Carrico is Associate Coordinator of The Corvallis Clinic Clinical Research Center
